Our commitment, to provide our customers with dependable reagents and to drive life science research, reflects the philosophy and approach we employ when we manufacture our products.

Through extensive study, development, and stringent testing, we have produced and validated a comprehensive collection of antibodies and research tools that researchers use every day to expand the limits of biomedical knowledge.

Quality

With a 20-year history of quality results, GeneTex sets itself apart from other antibody companies by taking the necessary steps to properly validate our antibodies. Antibody validation remains an industry-wide challenge with ramifications that can impact progress in the life sciences and medicine.

At GeneTex, product reliability is our primary concern. Stringent validation protocols have been established to test our antibodies for various applications, including WB, IP, IHC, IFA, FACS, and ELISA, using cell lines with known target protein expression levels and a diverse array of tissue samples. We know the importance of replicating results, so quality consistency between lots is maintained confidently through a combination of pre-qualified individual lots, dominant clones, and thorough quality control.

Founded by scientists, for scientists, we at GeneTex understand that researchers expect and demand product performance and fidelity. With GeneTex`s Knockout/Knockdown validation project, we`re committed to demonstrating to our customers that the products they are purchasing are completely reliable, every single time.

Our Commitment

There has been growing distrust of commercially available antibodies with regard to specificity and performance variability. As a result, the research community has demanded that antibody suppliers increase their efforts to more thoroughly validate their products. One approach to address this is through knockout or knockdown of the target protein.

At GeneTex, we continue to provide the research community with the highest quality and most stringently validated antibodies by utilizing CRISPR/Cas9- and shRNA-generated cell lysates for our western blot assays. To date, we have evaluated most of our featured products and will continue to expand these efforts throughout our entire antibody catalog.

GeneTex - Model SARS-CoV-2 (COVID-19)-[HL5511] - Nucleocapsid Antibody - Brochure